Literature DB >> 7497558

Effects of calcium channel blockers on circulatory response to tracheal intubation in hypertensive patients: nicardipine versus diltiazem.

Y Fujii1, H Tanaka, Y Saitoh, H Toyooka.   

Abstract

We studied the circulatory responses to laryngoscopy and tracheal intubation in 37 hypertensive patients who received nicardipine 30 micrograms.kg-1 iv (Group N, n = 12), diltiazem 0.3 mg.kg-1 (Group D, n = 12) or saline placebo (Group C, n = 13) 60 sec before the initiation of laryngoscopy. Anaesthesia was induced with thiopentone 5 mg.kg-1 iv, and succinylcholine 2 mg.kg-1 iv was used to facilitate tracheal intubation after precurarization with vecuronium 0.02 mg.kg-1 iv. In patients in Group C heart rate (HR) increased from 79 +/- 14 (baseline) to 110 +/- 12 (P < 0.05) associated with tracheal intubation; mean arterial pressure (MAP) increased from 116 +/- 8 to 140 +/- 77 (P < 0.05) and rate-pressure product (RPP) increased from 13385 +/- 2393 to 21251 +/- 3883 (P < 0.05). The changes from baseline values in HR and RPP after tracheal intubation in Group D were less than those in Groups C and N (P < 0.05). The increase in MAP following tracheal intubation in Groups N and D was lower than that in Group C (P < 0.05). We conclude that, compared with nicardipine, administration of diltiazem iv is associated with less circulatory response to tracheal intubation in hypertensive patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7497558     DOI: 10.1007/BF03011177

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  10 in total

1.  Circulatory changes during direct laryngoscopy and tracheal intubation: influence of duration of laryngoscopy with or without prior lidocaine.

Authors:  R K Stoelting
Journal:  Anesthesiology       Date:  1977-10       Impact factor: 7.892

2.  Effect of nicardipine on the cardiovascular response to tracheal intubation.

Authors:  K Mikawa; H Obara; M Kusunoki
Journal:  Br J Anaesth       Date:  1990-02       Impact factor: 9.166

3.  Complications related to the pressor response to endotracheal intubation.

Authors:  E J Fox; G S Sklar; C H Hill; R Villanueva; B D King
Journal:  Anesthesiology       Date:  1977-12       Impact factor: 7.892

4.  Studies of anaesthesia in relation to hypertension. II. Haemodynamic consequences of induction and endotracheal intubation.

Authors:  C Prys-Roberts; L T Greene; R Meloche; P Foëx
Journal:  Br J Anaesth       Date:  1971-06       Impact factor: 9.166

5.  Relation of heart rate and systolic blood pressure to the onset of pain in angina pectoris.

Authors:  B F Robinson
Journal:  Circulation       Date:  1967-06       Impact factor: 29.690

6.  Constancy of pressure-rate product in pacing-induced angina pectoris.

Authors:  D V Cokkinos; E M Voridis
Journal:  Br Heart J       Date:  1976-01

7.  [Attenuation of cardiovascular response to laryngoscopy and tracheal intubation with bolus injection of diltiazem].

Authors:  J Hasegawa; H Mitsuhata; S Matsumoto; K Enzan
Journal:  Masui       Date:  1992-03

8.  [Comparison between diltiazem and nicardipine used during anesthesia for coronary revascularization].

Authors:  Y Furuya; K Atarashi; C Tachibana; N Kobayashi; K Satoh; Y Ohe
Journal:  Masui       Date:  1994-04

9.  The effect of diltiazem on the cardiovascular response to tracheal intubation.

Authors:  K Mikawa; J Ikegaki; N Maekawa; R Goto; H Kaetsu; H Obara
Journal:  Anaesthesia       Date:  1990-04       Impact factor: 6.955

10.  Effects of nicardipine on the circulatory responses to tracheal intubation in normotensive and hypertensive patients.

Authors:  K Omote; A Kirita; A Namiki; H Iwasaki
Journal:  Anaesthesia       Date:  1992-01       Impact factor: 6.955

  10 in total
  1 in total

Review 1.  Intravenous nicardipine: its use in the short-term treatment of hypertension and various other indications.

Authors:  Monique P Curran; Dean M Robinson; Gillian M Keating
Journal:  Drugs       Date:  2006       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.